Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06250270 · ClinicalTrials.gov registry record · Early Phase 1
Effects of Casein Protein on Metabolism When Taken Prior to Sleep and in the Morning
A Early Phase 1 study of Metabolism, sponsored by Ohio University.
- Active
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06250270 is a Early Phase 1 study of Metabolism that is active but no longer recruiting, run by Ohio University. The registered enrollment target is 15 participants, below the 13,265-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06250270, a Early Phase 1 study of Metabolism, is active but no longer recruiting, sponsored by Ohio University.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the effect of casein protein consumption both prior to sleep as well first thing in the morning on metabolism (increase satiety and appetite, lower resting metabolic rate, and lower blood sugar levels), when compared to nighttime protein or placebo consumption alone. Protein itself is a macronutrient that not only helps the body repair itself, and play a critical role in growth, it also aids in increasing satiety and decreasing appetite. Casein protein specifically is slow digesting dairy protein which may impact the body's metabolism for a longer period than other dairy proteins such as whey. The literature demonstrates nighttime protein ingestion prior to sleep increases metabolic rate and satiety the next morning. However, there appears to be no data on the metabolic effects of protein ingested both at night and in the morning.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT protein or placebo
Study Locations (1)
Ohio
- Ohio University Exercise Physiology Lab - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2025-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06250270
The ClinicalTrials.gov registry entry for NCT06250270 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 13,265-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower). The listed sponsor is Ohio University, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metabolism appearing as the primary indexed condition, and to 1 intervention - of which protein or placebo is the first listed.
NCT06250270 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06250270 about?
NCT06250270 is a clinical study titled "Effects of Casein Protein on Metabolism When Taken Prior to Sleep and in the Morning". The purpose of this study is to investigate the effect of casein protein consumption both prior to sleep as well first thing in the morning on metabolism (increase satiety and appetite, lower resting metabolic rate, and lower blood sugar levels), when compared to nighttime protein or placebo consump...
What is the current status of trial NCT06250270?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2022-10-01. Estimated completion is 2025-12-31.
What conditions does trial NCT06250270 study?
This clinical trial studies the following conditions: Metabolism.
What interventions are being tested in trial NCT06250270?
The interventions under investigation include: protein or placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06250270?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06250270 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women
RECRUITING · NA
-
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
RECRUITING · Phase 2
-
Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants
RECRUITING
-
Caloric Balance Markers Study
RECRUITING
-
Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells
RECRUITING · NA
-
Personalized Responses to Dietary Composition Trial 3
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.